AMPAKINE® CX717 - no more sleep deprivation

further progress has been made by Cortex on its drug CX717 that enchances performance for those who suffer sleep deprivation, by reversing changes in the brain patterns.It has been tested in sleep-deprived humans with positive results, according to the developer, Cortex Pharmaceuticals. Some poor monkeys were kept awake for 36 hours and showed increased attentiveness in tests than those who weren't given the pill. As results from the study are proving more encouraging , this could be advantageous to those suffering from Alzheimer’s Disease, Attention Deficit Hyperactivity Disorder (ADHD), and sleep disorders. The drug, known as an ampakine, is designed to target AMPA receptors that are located throughout the brain. These receptors are part of the cellular communication process that involves the neurotransmitter glutamate. The drug prolongs the action of glutamate, allowing more effective communication. As the drug acts differently from caffeine and other stimulants, it does not seem to result in side effects such as hyperactivity, distorted thinking or extended wakefulness. good for people who work day shifts, fall asleep at the wheel, jet lag, sufferers of narcolepsy and I suppose an alternative to those who pop Ritalin for kicks !!